JFlorio wrote:
It should, but when a lying administration politicizes the science it can no longer be trusted.
Unfortunately you right!!! At this point none of us know what we can believe, rely on, or even properly vet because there is so much miss information.
What we are beginning to see now is concerning especially when some of the things that are now showing positive/negative were initially denied infatically..
A perfect example is the Johnson & Johnson vaccine where it was almost immediately claimed blood clots and myocarditis were at issue. What do we do, we put a hold on it and by April it’s back up and going..
Now we see there is actual validity to these concerns that were later dismissed when in fact they knew otherwise.. If I can find an article from the UK and their concerns over the JNJ vaccine I’ll post next. Significantly more disclosed regarding the problem with the Johnson & Johnson vaccine. It needs to be pulled…
The CDC cover up becomes harder each “ experimental day” of the vaccine(s) administered…
Originally published: April 21, 2021. Updated: December 16, 2021.]
Note: Information in this article was accurate at the time of original publication. Because information about COVID-19 changes rapidly, we encourage you to visit the websites of the Centers for Disease Control & Prevention (CDC), World Health Organization (WHO), and your state and local government for the latest information.
In the minds of many, the almost two-week halt of the Johnson & Johnson vaccine in April delivered doubt just as the mass COVID-19 vaccinations were making progress. There are three vaccines authorized for use in the United States, but Johnson & Johnson’s is a particularly important one, partly because its one-shot dose could help achieve herd immunity faster. In early April, the government recommended pausing the company’s vaccine after six women who received it developed rare blood clots—and one woman died.
But in late April, the Food and Drug Administration (FDA) decided to add a warning label about an uncommon, but potentially serious, blood clotting disorder. This decision followed a vote by a panel of advisers to the Centers for Disease Control and Prevention (CDC) to end the pause. This clears the way for states to resume vaccinations with the Johnson & Johnson vaccine.
Six cases is a small number, considering that over 6.8 million Johnson & Johnson shots had been administered as of April 12. (By May, 9 million doses had been administered and the number of rare blood clot cases had grown to 28, six of them in men, according to the CDC. At that point, three people had died.)
So, why did the pause occur?
Focusing on the word “pause” is key to understanding what happened with the Johnson & Johnson vaccine. “Putting a pause on a new vaccine or medication is not unusual. Even after it has completed its clinical trials, a vaccine still must be monitored in the real world,” says Yale Medicine infectious diseases specialist Jaimie Meyer, MD, MS. “If there are serious adverse events, we need to stop, take a deep breath, collect and analyze the data—and really try to understand why this is happening. Then, we can decide whether we should proceed.”
Transparency is also important, Dr. Meyer adds. “People should know that there are these events that have been observed—even if they are very rare events—so they can make informed choices,” she says.
What we know so far
Pausing the Johnson & Johnson vaccine was a response to the six cases reported in late March and early April to the Vaccine Adverse Events Reporting System (VAERS), a national early reporting warning system to detect safety problems with U.S.-licensed vaccines. All six people were women aged 18–48 years who experienced onset of symptoms between 6–13 (a median of nine) days.
Please read this article in full~~
https://www.yalemedicine.org/news/coronavirus-vaccine-blood-clotsThen read this one~~
https://m.theepochtimes.com/mkt_morningbrief/fda-strengthens-warning-over-severe-condition-linked-to-johnson-johnsons-covid-19-vaccine_4159815.html?utm_source=morningbriefnoe&utm_medium=email&utm_campaign=mb-2021-12-16&mktids=0e3272250766d8c4009018ab81c06dd9&est=hrBeLDU8NSVqP5BTRLOrDzJKQEzOMa62oZ4rsJ9GjBXKcUjqubqtEUghet3DJAam8Q%3D%3D